Rick E. Winningham - CHIEF EXECUTIVE OFFICER, Director at Theravance Biopharma, Inc.

Issuer-level insider activity

Role: CHIEF EXECUTIVE OFFICER, Director
Issuer ticker: TBPH on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Rick E. Winningham since 13 Sep 2025

Reported holdings for Rick E. Winningham in Theravance Biopharma, Inc.

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Theravance Biopharma, Inc.

Security class: Ordinary Shares
Shares / value: 1,611,022
Estimated value: $27,387,374
Report date: 20 Aug 2026
Price: $17.00
Ownership: Direct

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Theravance Biopharma, Inc.

Security class: Ordinary Shares
Shares / value: 92,567
Estimated value: $1,573,639
Report date: 20 Aug 2026
Price: $17.00
Ownership: By Trust

Form 4 holding CHIEF EXECUTIVE OFFICER, Director

Theravance Biopharma, Inc.

Security class: Ordinary Shares
Shares / value: 23,400
Estimated value: $397,800
Report date: 20 Aug 2026
Price: $17.00
Ownership: As Custodian

Transaction history for Rick E. Winningham in Theravance Biopharma, Inc.

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .